Summary
Christopher Bayly is a Principal Scientific Software Developer with over 30 years of experience applying computational chemistry to real-world drug discovery problems, currently building massively parallel, cloud-native affinity estimation capabilities for OpenEye/Cadence Molecular Sciences' Orion platform. He previously founded and led the Chemistry Modeling and Informatics group at Merck Frosst, guiding lead-optimization efforts from 1992 to 2010 and bridging chemistry, modeling, and project teams. With a PhD in Computational Chemistry from the University of New Brunswick, he blends deep domain science with scalable software engineering to turn complex simulations into routine, production-ready services. Based in Santa Fe, he operates as an independent consultant as well as an in-house principal developer, a dual role that keeps him close to both innovative research and practical deployment challenges. He is especially known for translating legacy modeling approaches into cloud-parallel workflows that accelerate throughput without sacrificing scientific rigor.
10 years of coding experience
PhD, Computational Chemistry, PhD, Computational Chemistry at University of New Brunswick